Orbital lymphoma and leukemias

Gunalp I., Gunduz K.

ANNALS OF OPHTHALMOLOGY & GLAUCOMA, cilt.30, sa.2, ss.95-98, 1998 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 2
  • Basım Tarihi: 1998
  • Dergi Adı: ANNALS OF OPHTHALMOLOGY & GLAUCOMA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
  • Sayfa Sayıları: ss.95-98
  • Ankara Üniversitesi Adresli: Evet

Özet

Orbital lymphoma and leukemias are the most common primary malignancy of the orbit We reviewed our results in the management of 56 orbital lymphoma and leukemia cases over a 32-year period. All had orbital biopsies. Treatment included radiotherapy (1,500 to 3,500 cGY, depending on the malignancy of the histology) in non-Hodgkin's lymphoma and lymphoplasmacytoid tumors, systemic chemotherapy plus orbital irradiation in Hodgkin's lymphoma, and reticulum cell sarcoma and chemotherapy in Burkitt's lymphoma and leukemias. At a mean follow-up of 5 years, 32.1% of the patients died. Orbital lymphoma and leukemias can be potentially fatal.